Literature DB >> 2881938

High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids.

K Reiff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881938     DOI: 10.1016/0378-4347(87)80254-2

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  9 in total

1.  Pharmacokinetic and blood pressure effects of carvedilol in patients with chronic renal failure.

Authors:  B K Krämer; K M Ress; C M Erley; T Risler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Novel carvedilol analogues that suppress store-overload-induced Ca2+ release.

Authors:  Chris D Smith; Aixia Wang; Kannan Vembaiyan; Jingqun Zhang; Cuihong Xie; Qiang Zhou; Guogen Wu; S R Wayne Chen; Thomas G Back
Journal:  J Med Chem       Date:  2013-11-05       Impact factor: 7.446

3.  Lack of a pharmacokinetic interaction between carvedilol and digitoxin or phenprocoumon.

Authors:  S Harder; R Brei; S Caspary; P G Merz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D McTavish; D Campoli-Richards; E M Sorkin
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

5.  Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.

Authors:  D P Brooks; B G Short; M J Cyronak; L C Contino; M DiCristo; Y X Wang; R R Ruffolo
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker.

Authors:  E von Möllendorff; K Reiff; G Neugebauer
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics and pharmacodynamics of carvedilol.

Authors:  T Morgan
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

8.  Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.

Authors:  G Neugebauer; W Akpan; B Kaufmann; K Reiff
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Sensitive assay for carvedilol in tablets and spiked human plasma using a flow-injection chemiluminometric method.

Authors:  Nawal Al Arfaj; Heba H Abdine; Maha A Sultan
Journal:  Int J Biomed Sci       Date:  2007-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.